Welcome to our dedicated page for HENRY SCHEIN SEC filings (Ticker: HSIC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Henry Schein, Inc. SEC filings document the formal disclosures of a Nasdaq-listed health care solutions company serving dental and medical practices and alternate care sites. The company’s 8-K filings report operating results, financial condition updates, press-release exhibits, leadership changes, board actions, and executive-compensation matters.
Proxy materials cover annual meeting matters, director and board-governance disclosures, and stockholder voting procedures. The filing record also identifies Henry Schein’s common stock, par value $0.01 per share, traded under HSIC on the Nasdaq Global Select Market, along with related corporate and Inline XBRL cover-page disclosures.
Faig Carole T reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein director Carole T. Faig received an equity grant from the company. She was awarded 2,577 restricted stock units relating to common stock at a stated price of $0.00 per share as a grant or award.
According to the grant terms, these restricted stock units were issued under Henry Schein's 2023 Non-Employee Director Stock Incentive Plan and generally vest after a 12‑month cliff period, conditioned on her continued service to the company. Following this award, her directly held common stock-related holdings total 8,025 shares.
Henry Schein director Deborah Derby reported an equity award of 2,577 shares of common stock on March 6, 2026. The shares were acquired at a stated price of $0.00 per share as a grant under the company’s 2023 Non-Employee Director Stock Incentive Plan.
According to a footnote, the award consists of restricted stock units that generally vest after a 12-month cliff period, subject to certain exceptions and Ms. Derby’s continued service to Henry Schein. Following this grant, she directly holds a total of 15,093 shares and is also reported as indirect owner, as trustee, of 760 shares held in a trust for her benefit.
DANIEL WILLIAM K reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein Inc. director Daniel William K received an equity award of 2,577 shares of common stock on March 6, 2026, granted at $0.00 per share under the 2023 Non-Employee Director Stock Incentive Plan. These restricted stock units vest after 12 months of continued service. Following the grant, he holds 5,426 shares directly and 10,000 shares indirectly through a trust where he and his spouse serve as co-trustees.
BERGMAN STANLEY M reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein Inc. director Stanley M. Bergman reported several stock-related updates involving company common stock. An indirect transaction moved 3,812 shares held via the Bergman Family Trust #2 to a related trust associated with his spouse. Following this, those indirect holdings totaled 379,991 shares held through spouse-related trusts and an LLC.
Bergman also received an award of 2,577 restricted stock units under Henry Schein’s 2023 Non-Employee Director Stock Incentive Plan. These units generally vest after 12 months, conditioned on continued service, bringing his directly held shares to 255,789. The filing further updates his indirect interest in 9,833 equivalent shares held through the Henry Schein 401(k) Savings Plan’s unitized stock fund.
Henry Schein Inc. director Ali Mohamad reported an equity award in the form of common stock. On March 6, 2026, he acquired 2,577 shares at no purchase price through a grant categorized as a grant, award, or other acquisition. The award was made under the company’s 2023 Non-Employee Director Stock Incentive Plan. According to the footnote, these restricted stock units vest after a 12‑month cliff period, and vesting depends on Mohamad continuing to provide services to the company. Following this grant, his directly held common stock position increased to 15,075 shares.
Henry Schein Inc. executive Mark E. Mlotek, EVP and Chief Strategic Officer, reported several transactions in the company’s common stock. On March 4, 2026, he made open-market sales of 4,100 shares at $80.795 per share and 1,825 shares at $80.811 per share.
He also made bona fide gifts of 1,215 shares on March 5, 2026 and 300 shares on March 6, 2026 at a stated price of $0.00 per share, including transfers to family trusts where he serves as trustee. Following these transactions, he directly held 77,539 shares, with additional indirect holdings of 7,416 shares in family trusts and 4,085 equivalent shares through the Henry Schein 401(k) Savings Plan.
Henry Schein Inc. director Philip A. Laskawy sold shares of the company. On March 5, 2026, he completed an open-market sale of 2,844 shares of common stock at a price of $80.36 per share. After this transaction, he directly owned 21,961 shares of Henry Schein common stock.
HSIC submitted a Form 144 notice relating to proposed sales of Common stock. The filing lists two tranches tied to restricted stock vesting: 556 shares dated 03/03/2024 and 4,739 shares dated 03/03/2025. The filing names Fidelity Brokerage Services LLC as the broker and shows a filing date of 03/04/2026.
Henry Schein Inc. reported that CEO Frederick M. Lowery acquired a sign-on equity-based award of 30,723 shares of common stock in the form of restricted stock units under the company’s 2024 Stock Incentive Plan. The RSUs vest in three equal annual installments, contingent on his continued service.